Traditional transoral approach and lateral pharyngotomy in surgical treatment of T1–2 oropharyngeal cancer

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Introduction. Growing incidence of oropharyngeal cancer is one of the reasons for increased interest in possibilities of surgical treatment of this pathology which currently is associated with not always available robot-assisted interventions. Therefore, study of the efficacy of traditional surgical accesses is of certain interest.

Aim. To analyze the effectiveness of transoral access and lateral pharyngotomy in T1–2 squamous cell oropharyngeal cancer.

Materials and methods. The study included 74 patients, ages between 34 and 74 years (mean age 55.3 ± 9.1), with squamous cell carcinoma of the palatine tonsils and root of the tongue. In 38 cases, primary tumor was resected through transoral access (group 1); in 36 cases, using lateral pharyngotomy (group 2). Analysis of postoperative period included evaluation of the number and type of complications, number of repeat surgical interventions, duration of tube feeding and hospitalization. Treatment efficacy was determined taking into account the incidence of local and regional recurrences, locoregional control, and overall survival.

Results. Complication rate, mean tube feeding and hospitalization times in the 2nd group were significantly higher than in the 1st group: 36 % versus 3 %, 14.3 days versus 10.6 days and 17.0 days versus 10.4 days, respectively. No differences between the numbers of repeat surgeries and cases of salivary fistula formation were found. With median follow-up of 47 (4–122) months, rates of local and regional recurrences in the 1st and 2nd groups were 11 and 11 %, 11 and 13 %, respectively. In group 1, locoregional control was achieved in 84 % patients; in group 2, in 81 %. Distant metastases were diagnosed in 8 and 17 % cases, respectively. There were no statistically significant differences in this parameter between the groups. Five-year overall survival in the total cohort was 71.2 %.

Conclusion. The use of transoral access and lateral pharyngotomy in T1–2 oropharyngeal cancer is characterized by relatively high efficacy and acceptable rate of postoperative complications.

About the authors

A. V. Karpenko

Leningrad Regional Clinical Hospital

Author for correspondence.
Email: andrei_karpenko@mail.ru
ORCID iD: 0000-0002-4756-1310
Russian Federation, Bld. 2, 45 Lunacharskogo Prospekt, Saint Petersburg, 194291

R. R. Sibgatullin

Leningrad Regional Clinical Hospital

Email: andrei_karpenko@mail.ru
ORCID iD: 0000-0003-3219-4420
Russian Federation, Bld. 2, 45 Lunacharskogo Prospekt, Saint Petersburg, 194291

A. A. Boyko

Leningrad Regional Clinical Hospital

Email: andrei_karpenko@mail.ru
ORCID iD: 0000-0003-1400-7775
Russian Federation, Bld. 2, 45 Lunacharskogo Prospekt, Saint Petersburg, 194291

O. M. Nikolaeva

Leningrad Regional Clinical Hospital

Email: andrei_karpenko@mail.ru
ORCID iD: 0000-0003-3658-4493
Russian Federation, Bld. 2, 45 Lunacharskogo Prospekt, Saint Petersburg, 194291

A. S. Kucherenko

Leningrad Regional Clinical Hospital

Email: andrei_karpenko@mail.ru
ORCID iD: 0000-0002-5861-190X
Russian Federation, Bld. 2, 45 Lunacharskogo Prospekt, Saint Petersburg, 194291

S. M. Alekseev

Leningrad Regional Clinical Hospital

Email: andrei_karpenko@mail.ru
ORCID iD: 0000-0001-7818-5429
Russian Federation, Bld. 2, 45 Lunacharskogo Prospekt, Saint Petersburg, 194291

References

  1. Wilkie M.D., Upile N.S., Lau A.S. et al. Transoral laser microsurgery for oropharyngeal squamous cell carcinoma: a paradigm shift in therapeutic approach. Head Neck 2016;38(8):1263–70. doi: 10.1002/hed.24432
  2. Justesen M.M., Jakobsen K.K., Carlander A-L.F. et al. Outcomes of transoral robotic surgery for early-stage oropharyngeal squamous cell carcinoma with low rates of adjuvant therapy: a consecutive single-institution study from 2013 to 2020. Oral Oncol 2024;152:106783. doi: 10.1016/j.oraloncology.2024.106783
  3. Zumsteg Z.S., Luu M., Rosenberg P.S. et al. Global epidemiologic patterns of oropharyngeal cancer incidence trends. J Natl Cancer Inst 2023;115(12):1544–54. doi: 10.1093/jnci/djad169
  4. Gupta K.K., De M., Athanasiou T. et al. Quality of life outcomes comparing primary Transoral Robotic Surgery (TORS) with primary radiotherapy for early-stage oropharyngeal squamous cell carcinoma: A systematic review and meta-analysis. Eur J Surg Oncol 2024;50(7):108434. doi: 10.1016/j.ejso.2024.108434
  5. Jacobs D., Torabi S.J., Park H.S. et al. Revisiting the radiation therapy oncology group 1221 hypothesis: treatment for stage III/IV HPV-negative oropharyngeal cancer. Otolaryngol Head Neck Surg 2021;164(6):1240–8. doi: 10.1177/0194599820969613
  6. Rahmati R., Dogan S., Pyke O. et al. Squamous cell carcinoma of the tonsil managed by conventional surgery and postoperative radiation. Head Neck 2015;37(6):800–7. doi: 10.1002/hed.23679
  7. Tirelli G., Bertolin A., Guida F. et al. Postoperative outcomes of different surgical approaches to oropharyngeal squamous cell cancer: a case-matched study. J Laryngol Otol 2021;135(4):348–54. doi: 10.1017/S0022215121000876
  8. Laccourreye O., Villeneuve A., Rubin F., Holsinger F.C. Lateral pharyngotomy. Eur Ann Otorhinolaryngol Head Neck Dis 2019;136(2):135–40. doi: 10.1016/j.anorl.2018.10.011
  9. Lee S.Y., Park Y.M., Byeon H.K. et al. Comparison of oncologic and functional outcomes after transoral robotic lateral oropharyngectomy versus conventional surgery for T1 to T3 tonsillar cancer. Head Neck 2014;36(8):1138–45. doi: 10.1002/hed.23424
  10. Golusiński W., Golusińska-Kardach E. Current role of surgery in the management of oropharyngeal cancer. Front Oncol 2019;9:388. doi: 10.3389/fonc.2019.00388
  11. Holsinger F.C., McWhorter A.J., Ménard M. et al. Transoral lateral oropharyngectomy for squamous cell carcinoma of the tonsillar region: I. Technique, complications, and functional results. Arch Otolaryngol Head Neck Surg 2005;131(7):583–91. doi: 10.1001/archotol.131.7.583
  12. Bertolin A., Ghirardo G., Lionello M. et al. Lateral pharyngotomy approach in the treatment of oropharyngeal carcinoma. Eur Arch Otorhinolaryngol 2017;274(6):2573–80. doi: 10.1007/s00405-017-4538-3
  13. Laccourreye O., Malinvaud D., Alzahrani H. et al. Conventional transoral surgery for stage I–II squamous cell carcinoma of the tonsillar region. Head Neck 2013;35(5):653–9. doi: 10.1002/hed.23018
  14. Rodrigo J.P., Díaz-Molina J.P., Moreno C., Suárez C. Oncologic and functional results after transhyoid surgical approach for cancer for the base of tongue. Head Neck 2011;33(8):1079–84. doi: 10.1002/hed.21569
  15. Meccariello G., Bianchi G., Calpona S. et al. Transoral robotic surgery versus definitive chemoradiotherapy for oropharyngeal cancer: 10-year institutional experience. Oral Oncol 2020;110:104889. doi: 10.1016/j.oraloncology.2020.104889
  16. Trotter W. A method for lateral pharyngotomy for the exposure of large growths in the epilaryngeal region. J Laryngol Rhinol Otol 1920;35(10):289–95. doi: 10.1017/S1755146300021181
  17. Moore E.J., Van Abel K.M., Price D.L. et al. Transoral robotic surgery for oropharyngeal carcinoma: Surgical margins and oncologic outcomes. Head Neck 2018;40(4):747–75. doi: 10.1002/hed.25055

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2026 ABV-Press

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77-36990 от  21.07.2009.